| Active substance |
Buspirone |
| Also known as |
Buspar, Busp |
| Blood pressure |
Generally has minimal effect on blood pressure |
| Chemical name |
8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione |
| Dosage (medical) |
10-30 mg daily in divided doses |
| Dosage (sports) |
Not applicable |
| Effects |
Reduces symptoms of anxiety |
| Formula |
C21H31N5O2 |
| Half-life |
2-3 hours |
| Hepatotoxicity |
Low risk |
| Lab Test |
Not specified |
| Main action |
Anxiolytic |
| Side effects |
Dizziness, headache, nausea, nervousness |
| Storage conditions |
Store at room temperature, protect from light |
| Strength |
10mg |
| Substance class |
Azapirone |
| Trade name |
Buspar |
| Use in sports |
None |
| Water Retention |
No significant effect |
| Manufacturer |
Intas Pharmaceuticals Ltd. |
| Packing |
10 tabs/blister |
